comparemela.com
  1. Home
  2. Live Updates
  3. Stephena Strugnell - Breaking News

Latest Breaking News On - Stephena strugnell - Page 1 : comparemela.com

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023 - OPKO Health (NASDAQ:OPK)

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ:OPK) will present late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney

United statesCharlesw bishopAkhtar ashfaqLyvonne briggsBruce vossStephena strugnellHealth incDrug administrationAmerican society of nephrologyExchange commissionAmerican societyKidney weekSecondary hyperparathyroidismExtended release calcifediolExhibit hallsb dCalcifediol overcomes impact

OPKO Health to Present New Clinical Data on Rayaldee (ER

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release.

United statesAkhtar ashfaqStephena strugnellBruce vossCharlesw bishopLyvonne briggsHealth incAmerican society of nephrologyDrug administrationExchange commissionAmerican societyKidney weekSecondary hyperparathyroidismExtended release calcifediolExhibit hallsb dCalcifediol overcomes impact

Excessive Body Weight Lessens the Efficacy of Vitamin D Supplements

Investigators examined the effects of vitamin D treatments, including cholecalciferol, ergocalciferol, and extended-release calcifediol in overweight patients with CKD.

United statesStephena strugnellRenal divisionVifor pharma ltdHealth incAmerican journalVifor pharma

Excessive Body Weight Lessens the Efficacy of Vitamin D Supplements

Investigators examined the effects of vitamin D treatments, including cholecalciferol, ergocalciferol, and extended-release calcifediol in overweight patients with CKD.

United statesStephena strugnellRenal divisionVifor pharma ltdHealth incAmerican journalVifor pharma

Excessive Body Weight Lessens the Efficacy of Vitamin D Supplements

Investigators examined the effects of vitamin D treatments, including cholecalciferol, ergocalciferol, and extended-release calcifediol in overweight patients with CKD.

United statesStephena strugnellHealth incAmerican journal

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.